{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:16:07Z","timestamp":1776784567116,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.japh.2024.102141","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:21:41Z","timestamp":1717590101000},"page":"102141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in Qatar"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-8831","authenticated-orcid":false,"given":"Rola","family":"Ghasoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-4401","authenticated-orcid":false,"given":"Shereen","family":"Elazzazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Benkhadra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-9964","authenticated-orcid":false,"given":"Nancy","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-4002","authenticated-orcid":false,"given":"Honar","family":"Cherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-9441","authenticated-orcid":false,"given":"Javid","family":"Gaziev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3614-6381","authenticated-orcid":false,"given":"Hesham","family":"Elsabah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-8521","authenticated-orcid":false,"given":"Anas","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2024.102141_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000442511","article-title":"Current trends of renal impairment in multiple myeloma","volume":"1","author":"Yadav","year":"2016","journal-title":"Kidney Dis"},{"issue":"1","key":"10.1016\/j.japh.2024.102141_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.japh.2024.102141_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.beha.2005.03.001","article-title":"Myeloma bone disease","volume":"18","author":"Berenson","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.japh.2024.102141_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/asheducation-2010.1.437","article-title":"Thrombosis in multiple myeloma","volume":"2010","author":"Kristinsson","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.japh.2024.102141_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2013.48.7934","article-title":"International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation","volume":"32","author":"Palumbo","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.japh.2024.102141_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11912-018-0686-x","article-title":"Prevalence and risk of polypharmacy among elderly cancer patients receiving chemotherapy in ambulatory oncology setting","volume":"20","author":"Goh","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.japh.2024.102141_bib8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1078155219880255","article-title":"Polypharmacy and comorbidities among ambulatory cancer patients: a cross-sectional retrospective study","volume":"26","author":"Alwhaibi","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"13","key":"10.1016\/j.japh.2024.102141_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1470-2045(11)70040-7","article-title":"Polypharmacy in elderly patients with cancer: clinical implications and management","volume":"12","author":"Lees","year":"2011","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.japh.2024.102141_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/1078155219851550","article-title":"Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician\u2013pharmacist clinic","volume":"26","author":"Sweiss","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"Supplement 1","key":"10.1016\/j.japh.2024.102141_bib11","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood-2018-99-117657","article-title":"Collaborative physician-pharmacist managed multiple myeloma clinic decreases polypharmacy, improves guideline adherence, and prevents treatment delays","volume":"132","author":"Sweiss","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.japh.2024.102141_bib12","series-title":"Implementation of pharmacist-led cancer clinics (PLCCs) with collaborative prescribing model at the national cancer center in Qatar","author":"Elazzazy","year":"2023"},{"issue":"5","key":"10.1016\/j.japh.2024.102141_bib13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1078155219882076","article-title":"Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar","volume":"26","author":"Omar","year":"2020","journal-title":"J\u00a0Oncol Pharm Pract [Internet]"},{"issue":"6","key":"10.1016\/j.japh.2024.102141_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1078155215608523","article-title":"Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia","volume":"22","author":"Lam","year":"2016","journal-title":"J\u00a0Oncol Pharm Pract [Internet]"},{"issue":"6","key":"10.1016\/j.japh.2024.102141_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2010.000033","article-title":"Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting","volume":"6","author":"Valgus","year":"2010","journal-title":"J\u00a0Oncol Pract [Internet]"},{"issue":"3","key":"10.1016\/j.japh.2024.102141_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s11096-020-01150-w","article-title":"Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation","volume":"43","author":"Schindler","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.japh.2024.102141_bib17","author":"Moss"},{"key":"10.1016\/j.japh.2024.102141_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1078155218783814","article-title":"A\u00a0systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies [Internet]","volume":"25","author":"Maleki","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"11","key":"10.1016\/j.japh.2024.102141_bib20","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00520-012-1385-z","article-title":"Pharmaceutical care for patients with breast and ovarian cancer","volume":"20","author":"Liekweg","year":"2012","journal-title":"Support Care Cancer [Internet]"},{"issue":"3","key":"10.1016\/j.japh.2024.102141_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.suponc.2011.09.005","article-title":"Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic","volume":"10","author":"Mancini","year":"2012","journal-title":"J\u00a0Support Oncol"},{"issue":"8","key":"10.1016\/j.japh.2024.102141_bib22","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1177\/1078155218820927","article-title":"Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: a retrospective cohort study","volume":"25","author":"Nasser","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"12","key":"10.1016\/j.japh.2024.102141_bib23","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:28:42Z","timestamp":1732040922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1544319124001614"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102141","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in Qatar","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102141"}}